JPMorgan Life Sciences Private Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
12
- Portfolio
-
11
- Exits
-
2
JPMorgan Life Sciences Private Capital General Information
Company Description
Founded in 2022, JPMorgan Life Sciences Private Capital is a venture capital investment firm based in New York. The firm is an investment arm of JP Morgan and seeks to invest in both early and growth-stage healthcare companies. The firm focuses on genetic medicine, oncology, neurodegenerative diseases, rare diseases, autoimmunity, artificial intelligence and machine learning platforms, metabolic diseases, and neuropsychology.
Business Details
Year Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- New York, NY
- United States
JPMorgan Life Sciences Private Capital Investments (12)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| GT Metabolic | 28-Oct-2026 | Later Stage VC | Surgical Devices | Generating Revenue | ||
| Korsana Biosciences | 07-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Averna Therapeutics | 19-Mar-2026 | Pharmaceuticals | Generating Revenue | |||
| Turbett Surgical | 27-Jan-2026 | Other Devices and Supplies | Generating Revenue | |||
| Korsana Biosciences | 01-Sep-2025 | Drug Discovery | Pre-Clinical Trials | |||
| ABK Biomedical | 09-May-2025 | Surgical Devices | Pre-Clinical Trials | |||
| Biolog | 10-Feb-2025 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Ottimo Pharma | 19-Dec-2024 | Drug Discovery | Generating Revenue | |||
| Pathalys Pharma | 07-Aug-2024 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 3 | ||
| Enlaza Therapeutics | 30-Apr-2024 | Early Stage VC | Drug Discovery | Generating Revenue |
JPMorgan Life Sciences Private Capital Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Achieve Life Sciences | 29-Feb-2024 |
JPMorgan Life Sciences Private Capital Investments by Industry, Year, and Region
JPMorgan Life Sciences Private Capital Co-Investors (40)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Samsara BioCapital | 3 |
|
|
||
| Invus (Private Equity) |
|
|
|||
| JP Morgan Asset Management |
|
|
|||
| Janus Henderson Investors |
|
|
|||
| OrbiMed |
|
|
JPMorgan Life Sciences Private Capital FAQs
-
What is JPMorgan Life Sciences Private Capital?
Founded in 2022, JPMorgan Life Sciences Private Capital is a venture capital investment firm based in New York.
-
When was JPMorgan Life Sciences Private Capital founded?
JPMorgan Life Sciences Private Capital was founded in 2022.
-
Where is JPMorgan Life Sciences Private Capital headquartered?
JPMorgan Life Sciences Private Capital is headquartered in New York, NY.
-
What is JPMorgan Life Sciences Private Capital's total asset value?
JPMorgan Life Sciences Private Capital has around in total assets under management.
-
How many investments has JPMorgan Life Sciences Private Capital made?
JPMorgan Life Sciences Private Capital has made 12 investments.
-
What has JPMorgan Life Sciences Private Capital invested in?
JPMorgan Life Sciences Private Capital has made numerous investments in companies like GT Metabolic, Korsana Biosciences, and Averna Therapeutics within the Surgical Devices, Drug Discovery, and Pharmaceuticals industries.
-
What has JPMorgan Life Sciences Private Capital invested in recently?
JPMorgan Life Sciences Private Capital's latest investment was on 28-Oct-2026 in GT Metabolic, a company within the Surgical Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process